Randomized Study Comparing a Basal-Bolus With a Basal Plus Correction Insulin Regimen for the Hospital Management of Medical and Surgical Patients With Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Effective and easily implemented insulin regimens are needed to facilitate hospital glycemic control in general medical and surgical patients with type 2 diabetes (T2D). RESEARCH DESIGN AND METHODS: This multicenter trial randomized 375 patients with T2D treated with diet, oral antidiabetic agents, or low-dose insulin (≤0.4 units/kg/day) to receive a basal-bolus regimen with glargine once daily and glulisine before meals, a basal plus regimen with glargine once daily and supplemental doses of glulisine, and sliding scale regular insulin (SSI). RESULTS: Improvement in mean daily blood glucose (BG) after the first day of therapy was similar between basal-bolus and basal plus groups (P = 0.16), and both regimens resulted in a lower mean daily BG than did SSI (P = 0.04). In addition, treatment with basal-bolus and basal plus regimens resulted in less treatment failure (defined as >2 consecutive BG >240 mg/dL or a mean daily BG >240 mg/dL) than did treatment with SSI (0 vs. 2 vs. 19%, respectively; P < 0.001). A BG <70 mg/dL occurred in 16% of patients in the basal-bolus group, 13% in the basal plus group, and 3% in the SSI group (P = 0.02). There was no difference among the groups in the frequency of severe hypoglycemia (<40 mg/dL; P = 0.76). CONCLUSIONS: The use of a basal plus regimen with glargine once daily plus corrective doses with glulisine insulin before meals resulted in glycemic control similar to a standard basal-bolus regimen. The basal plus approach is an effective alternative to the use of a basal-bolus regimen in general medical and surgical patients with T2D.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Intensive targets result in hypoglycemia, which, in turn, results in higher complications.105,106”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [106]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Intensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639
Standards of Medical Care in Diabetes—2012
(2012) · Diabetes Care · doi:10.2337/dc12-s011 · Cited by 2,240
Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes
Umpierrez, G. E., Isaacs, S. D., Bazargan, N., You, X., Thaler, L. M., & Kitabchi, A. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8341 · Cited by 2,195
Self-citationEarly versus late parenteral nutrition in critically ill adults
Casaer, M. P., Mesotten, D., Hermans, G., Wouters, P. J., Schetz, M., Meyfroidt, G., Van Cromphaut, S., Ingels, C., Meersseman, P., Muller, J., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102662 · Cited by 1,696 · cited 1×
“It is possible that increasing the starting insulin dose and increasing insulin titration will result in better glycemic control; however, it may also increase the risk of hypoglycemic events (28).”
BackgroundMoghissi, E. S., Korytkowski, M. T., DiNardo, M., Einhorn, D., Hellman, R., Hirsch, I. B., Inzucchi, S. E., Ismail-Beigi, F., Kirkman, M. S., & Umpierrez, G. E. (2009) · Diabetes Care · doi:10.2337/dc09-9029 · Cited by 1,444
Self-citationManagement of diabetes and hyperglycemia in hospitals.
Clement, S., Braithwaite, S. S., Magee, M. F., Ahmann, A., Smith, E. P., Schafer, R. G., Hirsch, I. B., & on behalf of the Diabetes in Hospitals Writing Committee (2004) · Diabetes Care · doi:10.2337/diacare.27.2.553 · Cited by 1,266 · cited 1×
“Insulin with oral agents 9 (6) 10 (8) 5 (7)”
Krinsley, J. S. (2003) · Mayo Clinic Proceedings · doi:10.4065/78.12.1471 · Cited by 1,165
Furnary, A. P., Gao, G., Grunkemeier, G. L., Wu, Y., Zerr, K. J., Bookin, S. O., Floten, H. S., & Starr, A. (2003) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1067/mtc.2003.181 · Cited by 1,130 · cited 2×
“The association between hyperglycemia and increased risk of hospital complications is well established in both ICU and non-ICU patients (3,4,6,8,21 – 23).”
BackgroundUmpierrez, G. E., Hellman, R., Korytkowski, M. T., Kosiborod, M., Maynard, G. A., Montori, V. M., Seley, J. J., & Van den Berghe, G. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2098 · Cited by 1,126
Self-citation
Cited by
Items 101–200 of 221
Seufert, J., Borck, A., & Bramlage, P. (2019) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-000679 · Cited by 12
Annals for hospitalists inpatient notes - how we treat hyperglycemia in the hospital
Pasquel, F. J., & Umpierrez, G. E. (2021) · Annals of Internal Medicine · doi:10.7326/m21-2789 · Cited by 9
Self-citationInpatient hyperglycemia and transitions of care: A systematic review
Lansang, M. C., Zhou, K., & Korytkowski, M. T. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.01.016 · Cited by 9
Perioperative Glycemic Control During Colorectal Surgery
Thompson, R. E., Broussard, E. K., Flum, D. R., & Wisse, B. E. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0722-x · Cited by 10
Selecting Insulin Regimens for the Management of Non-ICU Patients With Type 2 Diabetes
Migdal, A. L., Idrees, T., & Umpierrez, G. E. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab134 · Cited by 8
“25 units/kg/day) along with corrective doses of insulin by sliding scale for hyperglycemia before meals or every 6 h (if nil by mouth) [6].”
BackgroundSelf-citationToyoshima, M. T. K., Brandes, P. H. R., Lauterbach, G. D. P., Moraes, J. R. A., de Paiva, E. F., Umpierrez, G. E., Nery, M., & Kondo, R. H. (2022) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000496 · Cited by 11
“These results are similar to that of prospective randomized studies evaluating glycemic control and insulin therapy regimens, such as RABBIT2 (22), DEAN (23) and Basal Plus (5) studies.”
ResultSelf-citationAchieving Glycemic Control in Special Populations in Hospital: Perspectives in Practice
CHENG, A. Y. Y. (2014) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2014.02.021 · Cited by 10
Glucometrics and Insulinometrics
Thompson, B., & Cook, C. B. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0964-2 · Cited by 8
Gupta, T., & Hudson, M. (2017) · Journal of the Endocrine Society · doi:10.1210/js.2016-1055 · Cited by 7
Perioperative Management of Blood Glucose in Adults with Diabetes Mellitus
Wang, A., Yoon, J. A., Mirsaidi, N., & Schulman‐Rosenbaum, R. (2023) · Contemporary Endocrinology · doi:10.1007/978-3-031-44648-1_19 · Cited by 8
HAW, J. S., Farrokhi, F., Smiley, D. D., Peng, L., Reyes, D., Newton, C. A., Pasquel, F. J., Vellanki, P., & Umpierrez, G. E. (2015) · Endocrine Practice · doi:10.4158/ep14540.or · Cited by 7
Self-citationGoron, A. R., Connolly, C. T., Valdez‐Sinon, A. N., Hesson, A., Helou, C. M., & Kirschen, G. W. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13206259 · Cited by 11
“For non-critically ill inpatients requiring hospital admission, the preferred approach for insulin therapy is a basal regimen with correctional insulin, typically given when glucose levels are >150 mg/dL, although this may vary [18].”
BackgroundManagement of Hyperglycemia in Hospitalized Patients
Gianchandani, R. Y., Wei, M., & Demidowich, A. P. (2024) · Annals of Internal Medicine · doi:10.7326/annals-24-02754 · Cited by 12
Closer to closing the loop on inpatient glycaemia
Rayman, G. A. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30327-8 · Cited by 7
Management of Inpatient Hyperglycemia and Diabetes in Older Adults
Davis, G. M., DeCarlo, K., Wallia, A., Umpierrez, G. E., & Pasquel, F. J. (2020) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2020.04.008 · Cited by 8
“(39) randomized patients with type 2 diabetes to receive a basal-bolus regimen with glargine once daily and glulisine before meals and to a basal plus regimen with glargine once daily and supplemental doses of glulisine for correction of hyperglycemia per sliding scale.”
Self-citationEvidence-based therapeutics for hyperglycemia in hospitalized noncritically ill patients
Gracia‐Ramos, A. E., Carretero‐Gómez, J., Mendez, C. E., & Carrasco-Sánchez, F. J. (2021) · Current Medical Research and Opinion · doi:10.1080/03007995.2021.1997288 · Cited by 7
Inpatient Glycemic Protocol for Patients with Diabetes Undergoing Bariatric Surgery
Machnica, K., Pannain, S., Schulwolf, E., Bartfield, J. K., & Emanuele, M. A. (2015) · Obesity Surgery · doi:10.1007/s11695-015-1860-y · Cited by 6
Caimari, F., González, C., Ramos, A., Chico, A. I., Cubero, J. M., & Pérez, A. (2016) · Cirugía Española (English Edition) · doi:10.1016/j.cireng.2016.08.001 · Cited by 7
Caimari, F., González, C., Ramos, A., Chico, A. I., Cubero, J. M., & Pérez, A. (2015) · Cirugía Española · doi:10.1016/j.ciresp.2015.02.007 · Cited by 9
Ghosh, S. K., Unnikrishnan, A. G., Saboo, B., Kesavadev, J., Aravind, S. R., Bajaj, S., Rajput, R., Seshadri, K., Verma, N., Gupta, A., et al. (2017) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2017.03.045 · Cited by 7
Noninsulin medication therapy for hospitalized patients with diabetes mellitus
Petite, S. E. (2018) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp170869 · Cited by 7
Ramos, A., Rabasa, F., Mendoza, L. C., Cardenete, J., Gill, P., Morilla, A., Cardona, D., & Pérez, A. (2018) · Diabetes Therapy · doi:10.1007/s13300-018-0433-1 · Cited by 7
Franchin, A., Maran, A., Bruttomesso, D., Corradin, M. L., Rossi, F., Zanatta, F., Barbato, G. M., Sicolo, N., & Manzato, E. (2017) · Aging Clinical and Experimental Research · doi:10.1007/s40520-017-0728-5 · Cited by 6
Morikawa, L. L., Nery, M., & Toyoshima, M. T. K. (2026) · Endocrine Practice · doi:10.1016/j.eprac.2026.01.024 · Cited by 6
Self-citationMarino, E. C., Momesso, D., Toyoshima, M. T. K., de Almeida, M. F. O., Schaan, B. D., Negretto, L. A. F., Junior, A. C. S., Cukier, P., Genestreti, P., Feitosa, A. C. R., et al. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01585-z · Cited by 10
Self-citationSáenz-Abad, D., Gimeno-Orna, J. A., Sierra-Bergua, B., Lahoza-Pérez, M. C., & Pérez‐Calvo, J. I. (2015) · Anales del Sistema Sanitario de Navarra · doi:10.4321/s1137-66272015000300004 · Cited by 7
Ketz, J. M., Yeh, E. J., & Suri, S. (2019) · Clinical Diabetes · doi:10.2337/cd19-0003 · Cited by 5
Development of insulin and its pharmacology and perioperative use: a narrative review
Dhatariya, K., Levy, N., Stubbs, D. J., Frank, C., Tinsley, S. L., & Knaggs, R. (2025) · British Journal of Anaesthesia · doi:10.1016/j.bja.2025.05.006 · Cited by 8
“It is a prerequisite that these regimes are only used if the patient will have one missed meal.”
Non-ICU Hospital Care of Diabetes Mellitus in the Elderly Population
Gilden, J. L., & Gupta, A. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0596-3 · Cited by 7
Cardiovascular Safety of Antidiabetic Drugs in the Hospital Setting
Seggelke, S. A., Lindsay, M. C., Hazlett, I., Sanagorski, R., Eckel, R. H., & Wang, C. C. L. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0884-1 · Cited by 7
Manejo de pacientes diabéticos hospitalizados
Román-Gonzaléz, A., Cardona, A., Gutiérrez-Restrepo, J., & Palacio, A. (2018) · Revista de la Facultad de Medicina · doi:10.15446/revfacmed.v66n3.61890 · Cited by 15
Evaluation of Dipeptidyl Peptidase-IV Inhibitor Use in the Inpatient Setting
Petite, S. E., & Hill, M. C. (2020) · Journal of Pharmacy Practice · doi:10.1177/0897190020966150 · Cited by 5
“8 CCI 4 (2-6) 5 (2-7) 4 (2-6) 4 (3-6) 0.”
Cuervo, C. G., Morla, A. S., Asín, M. A. P., Pardo, O. B., Ordoño, L. P., & Santos, J. V. (2016) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2015.11.008 · Cited by 6
Kanjee, Z., Brown, F. M., Taxin, Z. H., & Smetana, G. W. (2024) · Annals of Internal Medicine · doi:10.7326/annals-24-01100 · Cited by 5
Petite, S. E., Huenecke, J., & Tuttle, N. (2019) · Hospital Pharmacy · doi:10.1177/0018578719841029 · Cited by 4
“The study population was similar to the Basal-Plus trial, evaluating a combined non-ICU and surgical cohort.(8) Administration of a basal insulin containing regimen, with either bolus mealtime and/or sliding scale insulin, compared with sliding scale insulin alone resulted in superior glycemic control with an increase…”
BackgroundResultEvaluation of Dipeptidyl Peptidase-IV Inhibitor Use in Hospitalized Patients With Diabetes
Petite, S. E., & Hill, M. C. (2021) · Annals of Pharmacotherapy · doi:10.1177/1060028021996337 · Cited by 4
“There was a significant difference in hospital LOS (5 [interquartile range = 3-8] vs 6 [4-11] days; P = 0.”
BackgroundHochfellner, D. A., Rainer, R., Ziko, H., Aberer, F., Simic, A., Lichtenegger, K. M., Beck, P., Donsa, K., Pieber, T. R., Fruhwald, F. M., et al. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14458 · Cited by 5
López-Huamanrayme, E., Garate, D., Espinoza‐Morales, F., Del-Castillo-Ochoa, S., Gómez-Noronha, A. A., Salsavilca, E., Taype-Rondán, Á., & Pasquel, F. J. (2021) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2021.100265 · Cited by 7
“…control due to data collection limitations, clinical trials in hospitalized patients with diabetes, conducted before the pandemic, have shown that basal or basal-bolus insulin regimens can lead to better glycemic control and a lower complication rate compared to SSI regimens [31,32,13 – 15].”
ResultUpdates on the Management of Hyperglycemia in Hospitalized Adult Patients
Razavi, L., & Omoregie, C. (2023) · Endocrines · doi:10.3390/endocrines4030037 · Cited by 7
“…sliding-scale [57] 3—Basal Plus trial: recommends the use of the basal-plus correction scale in surgical patients with a higher risk of hypoglycemia [58] Critically Ill pts on steroid: IV insulin infusion [30] Poor intake or NPO [58] Basal insulin (0.1– Normal intake [56,57] Basal insulin (0.1–”
BackgroundMethodInfluentialMeyrat, R. B., Vivian, E., Sridhar, A., Gulden, R. H., Bruce, S., Martinez, A., Montgomery, L. G., Reed, D. N., Rappa, P. J., Makanbhai, H., et al. (2023) · Medicine · doi:10.1097/md.0000000000036142 · Cited by 6
A toolbox to improve algorithms for insulin-dosing decision support
Donsa, K., Plank, J., Schaupp, L., Mader, J. K., Truskaller, T., Tschapeller, B., Höll, B., Spat, S., Pieber, T. R., & Beck, P. (2014) · Applied Clinical Informatics · doi:10.4338/aci-2014-04-ra-0033 · Cited by 4
Siegmund, T., Pfohl, M., Forst, T. M., Pscherer, S., Bramlage, P., Foersch, J., Borck, A., & Seufert, J. (2016) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2016.08.006 · Cited by 4
Wang, R., Kyi, M., Krishnamoorthi, B., Connell, A., Chiang, C. Y., Renouf, D., Barmanray, R., & Fourlanos, S. (2025) · Diabetic Medicine · doi:10.1111/dme.70076 · Cited by 3
Advanced Hybrid Closed-Loop Systems in Perioperative Care: Safety During Anesthesia
Medina, A. M. G., Henao, D. C., Múñoz, Ó., Maira, G., Hurtado, D., Vargas, C., Rojas-Acosta, G., & Zhong-Lin, C. (2025) · Diabetes Technology & Therapeutics · doi:10.1177/15209156251376011 · Cited by 4
Tran, M. N. T., Dang, K. T., Lý, Đ. L., & Tran, N. Q. (2022) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-022-01079-y · Cited by 3
Tang, H., Lai, Y., Zhao, E., Zeng, W., Zhou, K., & Zhou, Z. (2025) · The Journal of Arthroplasty · doi:10.1016/j.arth.2025.07.048 · Cited by 5
Evaluation of the Safety and Efficacy of Metformin Use in Hospitalized, Non–Critically Ill Patients
Alauddin, T., & Petite, S. E. (2020) · Journal of Pharmacy Technology · doi:10.1177/8755122520911689 · Cited by 6
Gracia‐Ramos, A. E., Cruz-Domínguez, M. P., & Madrigal‐Santillán, E. (2021) · Revista Clínica Española (English Edition) · doi:10.1016/j.rceng.2021.09.003 · Cited by 3
Kuchay, M. S., Mathew, A., Mishra, M., Surendran, P., Kaur, P., Wasir, J. S., Gill, H. K., Jain, R., Gagneja, S., Kohli, C., et al. (2022) · Diabetic Medicine · doi:10.1111/dme.15002 · Cited by 3
Cuervo, C. G., Morla, A. S., Asín, M. A. P., Pardo, O. B., Ordoño, L. P., & Santos, J. V. (2016) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2016.04.004 · Cited by 3
María, M. A. M., Ramos, A., Roldán, M. J. M., Giménez, I., & Pérez, A. (2019) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2019.07.010 · Cited by 3
Implementation of an inpatient hyperglycemia management program incorporating a nurse consultant
María, M. A. M., Ramos, A., Roldán, M. J. M., Giménez, I., & Pérez, A. (2020) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2020.08.012 · Cited by 3
Kanbour, S., Zale, A. D., Shim, J., Abusamaan, M. S., & Mathioudakis, N. N. (2025) · Endocrine Practice · doi:10.1016/j.eprac.2025.01.008 · Cited by 2
Ammar, A., Sorochak, N., Paxton, R. A., Lipari, M., & Giuliano, C. A. (2025) · Journal of Intensive Care Medicine · doi:10.1177/08850666251371709 · Cited by 2
Glycaemic management in patients with diabetes in hospital
Rajendran, R., & Rayman, G. A. (2014) · Medicine · doi:10.1016/j.mpmed.2014.09.010 · Cited by 3
Kaisen, A. R., Parkosewich, J. A., & Bonito, K. A. (2018) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721718760514 · Cited by 7
“Coordinating pre-meal CBG testing, insulin coverage, and meal intake increases the likelihood that the patient will have improved blood glucose control.(6-10) Despite these national inpatient mealtime glycemic control guidelines, adherence to these recommendations is a problem in clinical practice.”
BackgroundHypoglycemia in Critically Ill Patients
Ma, T., & Chen, L. L. (2024) · Critical Care Nursing Quarterly · doi:10.1097/cnq.0000000000000525 · Cited by 2
Avanzini, F., Marelli, G., Amodeo, R., Chiappa, L., Colombo, E. L., Rocco, E. D., Grioni, M., Moro, C., Roncaglioni, M. C., Saltafossi, D., et al. (2020) · Diabetic Medicine · doi:10.1111/dme.14293 · Cited by 2
[Management of hyperglycemia in hospitalized patients].
Gracia‐Ramos, A. E., Cruz-Domínguez, M. P., Madrigal‐Santillán, E., Morales‐González, J. A., & Lastra, O. L. V. (2015) · PubMed · Cited by 3
Myers, A. K., Garnica, P., & Ling, J. (2018) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000000667 · Cited by 5
Tang, S., Shih, S., Lin, S., Chen, C., Yeh, S., Tsai, L., Yang, W., & Jeng, J. (2021) · Scientific Reports · doi:10.1038/s41598-021-91036-2 · Cited by 2
Determinants of initial insulin therapy for hospitalized patients with diabetes mellitus
Chiang, H.-H., Surampudi, P. N., & Sood, A. (2022) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2022.108307 · Cited by 3
Gracia‐Ramos, A. E., Cruz-Domínguez, M. P., Madrigal‐Santillán, E., Rojas-Martínez, R., Morales‐González, J. A., Morales‐González, Á., Hernández-Espinoza, M., Vargas-Peñafiel, J., & Tapia-González, M. D. L. Á. (2024) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2024.108742 · Cited by 2
Cogle, S. V., & Hutchison, A. M. (2020) · Physician Assistant Clinics · doi:10.1016/j.cpha.2019.11.006 · Cited by 2
Glycemic Management in Insulin-Naive Patients in the Inpatient Setting
Goldstein, M. B., Islam, S., Nicolich-Henkin, S., Bellavia, L., & Klek, S. P. (2024) · Diabetes Spectrum · doi:10.2337/ds23-0007 · Cited by 1
Evaluating Intensive Insulin Therapy With Empagliflozin in Type 2 Diabetes: A Randomised Study
Fushimi, N., Hachiya, H., Iwasaka, T., Nagao, M., Masamura, T., Higashi, K., & Mori, A. (2025) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.70096 · Cited by 1
Soliman, D., Varghese, R. T., Umpierrez, G. E., & Galindo, R. J. (2025) · Medical Clinics of North America · doi:10.1016/j.mcna.2025.11.006 · Cited by 1
Self-citationMarino, E. C., Negretto, L. A. F., Ribeiro, R. S., Momesso, D., Feitosa, A. C. R., Toyoshima, M. T. K., da Silva, J. C., Vencio, S. A. C., Lauria, M. W., de Sá, J. R., et al. (2026) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-02060-5 · Cited by 3
Self-citationCamuto, P., Guadagnini, D., Assalin, H. B., Magro, D. O., Santos, A., & Saad, M. J. A. (2026) · AACE Endocrinology and Diabetes · doi:10.1016/j.aed.2026.06.010 · Cited by 1
Abu-Jlambo, A., AbuZarifa, M., Sawh, R. R. R., Subhash Reddy Narayana Reddy, N., Salman, M. B., Rampurawala, I. M., Ashour, Y., & Ayesh, H. (2026) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.70277 · Cited by 2
Cook, C. B., Apsey, H. A., Glasgow, A. E., Castro, J. C., Habermann, E. B., & Schlinkert, R. T. (2017) · Future Science OA · doi:10.4155/fsoa-2017-0099 · Cited by 1
Insulin Treatment in Hospitalized Patients
Moon, S. J., & Cho, Y. M. (2018) · Journal of Korean Diabetes · doi:10.4093/jkd.2018.19.4.214 · Cited by 1
“소위 sliding-scale 인슐린 주사는 이미 고혈당이 발생한 연후에라야 인슐린을 투여하는 까닭에 혈당강하 효 과가 낮아서 특수한 경우 외에는 사용하지 않음을 원칙으로 한다[14-17].”
Inpatient Management of Diabetes and Hyperglycemia
Horton, W. B. (2019) · Springer eBooks · doi:10.1007/978-3-030-11815-0_43 · Cited by 1
Perioperative Care of the Orthopedic Patient with Diabetes Mellitus
Gregory, N. S., & MacKenzie, C. R. (2020) · Springer eBooks · doi:10.1007/978-3-030-35570-8_16 · Cited by 1
Webster, R. E., Belfer, J. J., & Schmidt, K. J. (2023) · Annals of Pharmacotherapy · doi:10.1177/10600280231197255 · Cited by 1
Lavinas-Jones, J. M., Toyoshima, M. T. K., Mesquita, L. A., Nery, M., & Feitosa, A. C. R. (2025) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241306443 · Cited by 1
Self-citationPerioperative Care of the Orthopedic Patient with Diabetes Mellitus
MacKenzie, C. R., & Gregory, N. S. (2014) · Springer eBooks · doi:10.1007/978-1-4614-0100-1_14 · Cited by 1
Managing Diabetes in Patients Hospitalized in Internal Medicine Units
Hochberg, I. (2018) · Rambam Maimonides Medical Journal · doi:10.5041/rmmj.10334 · Cited by 1
Goyal, N., Rose, R., Johnson, S. A., Babbel, D., Plugge, T., Hodgkin, J., Simmons, D., & Yarbrough, P. (2022) · Journal for Healthcare Quality · doi:10.1097/jhq.0000000000000342 · Cited by 1
“Multiple studies have demonstrated that a strategy including basal insulin is superior to sliding scale insulin in achieving glucose control.(9,10) Current practice recommendations include stopping oral hypoglycemic agents and initiating basal-bolus insulin (BBI) while patients are hospitalized.”
BackgroundIn‐Hospital Treatment and Surgery in People with Diabetes
Dhatariya, K., Newland‐Jones, P., & Patel, M. A. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch39 · Cited by 3
Endocrine Perturbations in Critical Illness
Lee, G. S., Inzucchi, S. E., & Holt, E. H. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1121-9_14
“, glargine) and a correction scale of rapid-acting insulin at mealtimes, achieves similar glycemic control as the BBC regimen [ 50 ].”
Diabetes and Hyperglycemia in the Surgical Setting
DeFelice, N., & Thompson, R. E. (2016) · Hospital Medicine Clinics · doi:10.1016/j.ehmc.2015.11.006 · Cited by 1
Insulin Pump Therapy in Non-Pregnant Hospitalized Adults: A Review of the Literature
Gibson, J. M. (2014) · Journal of Nursing & Care · doi:10.4172/2167-1168.1000199
“Basal Plus” Insulin Achieves Outcomes Similar to Those of Basal Bolus Therapy
Calderon, A. J., FACP., F., & Sfhm (2013) · Journal watch · doi:10.1056/nejm-jw.na30913
Diabetes Mellitus: Diagnosis and Care
Giangola, J. (2019) · Organ and tissue transplantation · doi:10.1007/978-3-319-05257-1_2012
Glycemic Control in the Critically Ill Patient
Draznin, B. (2014) · The Endocrine Society eBooks · doi:10.1210/mtp3.9781936704835.ch22
Management of Diabetes in the Hospital
Korytkowski, M. T. (2015) · The Endocrine Society eBooks · doi:10.1210/mtp4.9781936704941.ch17
Leitgeb, S., & Mader, J. K. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816677296
In‐Hospital Treatment and Surgery in People with Diabetes
Dhatariya, K., & James, J. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch34 · Cited by 1
HSOA Journal of Diabetes and Metabolic Disorders Research Article
Fiorini, F., Sessa, F., Congedo, E., & COSMO, G. D. (2015)
Management of Diabetes and/or Hyperglycemia in Non‐Critical Care Hospital Settings
Galindo, R. J., & Umpierrez, G. E. (2018) · Wiley eBooks · doi:10.1002/9781119374800.ch30 · Cited by 2
Self-citationManagement of Concentrated Insulins in Acute Care Settings
SAYED, N. A. E., Ritter, M. J., & Segal, A. R. (2018) · Wiley eBooks · doi:10.1002/9781119374800.ch34
Principles of Care in the Diabetic Surgical Patient
Khazai, N. B., & Hamdy, O. (2018) · Contemporary diabetes · doi:10.1007/978-3-319-89869-8_6
Hypoglycemia in Patients with Diabetes
Hudson, M. (2020) · Springer eBooks · doi:10.1007/978-3-030-38976-5_23
PERI-OPERATIVE MANAGEMENT IN DIABETES MELLITUS
Sakthi Vignesh, G., & Nithianandam, S. (2020) · Indian Journal Of Applied Research · doi:10.36106/ijar/0600810
Lalwani, D., Muley, A., & Mahida, H. (2021) · Current Medical Issues · doi:10.4103/cmi.cmi_107_20
Vu, J., Ghanbari, H. M., Romanovsky, L., Coleman, B. L., & Fan‐Lun, C. (2021) · TSpace (University of Toronto)
Comparison of various basal insulin dose adjustments for inpatients while unable to eat
Eberhard, C. M., & Petite, S. E. (2021) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-021-01314-2
Gracia‐Ramos, A. E., Cruz-Domínguez, M. P., & Madrigal‐Santillán, E. (2021) · Revista Clínica Española · doi:10.1016/j.rce.2021.09.002
Endocrine Perturbations in Critical Illness
Holt, E. H. (2020) · Springer eBooks · doi:10.1007/978-3-030-39781-4_16
Metadata
- Authors
- Umpierrez, G. E., Smiley, D., Hermayer, K., Khan, A., Olson, D. E., Newton, C., Jacobs, S., Rizzo, M., Peng, L., Reyes, D., Pinzon, I., Fereira, M. E., Hunt, V., Gore, A., Toyoshima, M. T., & Fonseca, V. A.
- Affiliations
- Emory University (US)
- Medical University of South Carolina (US)
- Tulane Medical Center (US)
- Corresponding author
- Umpierrez, Guillermo E.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2013-07-11
- Volume
- 36
- Issue
- 8
- Pages
- 2169-2174
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3714500
- OpenAlex
- W2113123801
- Cited by
- 222
- References
- 29
- Citations by year
- 2026: 9 · 2025: 15 · 2024: 11 · 2023: 13 · 2022: 15 · 2021: 19 · 2020: 18 · 2019: 17 · 2018: 20 · 2017: 17 · 2016: 27 · 2015: 23 · 2014: 14 · 2013: 4
- FWCI
- 17.83
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (UL1TR000454)
- National Institute of General Medical Sciences (U54GM104940)
- National Center for Research Resources (UL1RR025008)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 2 diabetes, multiple daily insulin injections, glargine, glulisine, sliding scale insulin, hypoglycemia, hyperglycemia, surgical patients, medical patients
- MeSH terms
- Insulin Glargine, Adult, Aged, Blood Glucose, Diabetes Mellitus, Type 2, Female, Hospitalization, Humans, Hypoglycemic Agents, Insulin, Male, Middle Aged, Surgical Procedures, Operative, Treatment Outcome, Insulin, Long-Acting, Meals
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
